Novan to Present Anti-viral Data for Nitric Oxide Product Candidate SB206

Preclinical Data Demonstrating Novel Mechanism of Action for the Treatment of HPV-Associated Warts to be Presented During Society for Investigative Dermatology Annual Meeting

Novan, Inc. today announced that Kimberly McHale, Ph.D., Novan Senior Scientist, Research & Nonclinical Development, will present data demonstrating a novel mechanism of action for the Company’s anti-viral product candidate, SB206, Saturday, May 14, at the 75th Annual Meeting of the Society for Investigative Dermatology in Scottsdale, Ariz.